유럽의 어류 백신 시장 : 지역별 분석 - 백신 유형별, 용도별, 투여 경로별, 어종별, 예측(-2030년)

The Europe fish vaccines market was valued at US$ 110.00 million in 2022 and is expected to reach US$ 191.33 million by 2030; it is estimated to grow at a CAGR of 7.2% from 2022 to 2030.

Surging Demand for Aquatic Animal-Derived Food Products Fuel the Europe Fish Vaccines Market

An unhealthy diet is a growing concern in developing and developed countries, resulting in a variety of negative health consequences. Thus, fish is highly advisable in diet for healthy growth and development as it is rich in vitamins, minerals, lipids, and macronutrients such as proteins. Additionally, it is believed that aquaculture is the most effective way to produce high-quality proteins for a sustainable human diet. Growing awareness regarding the nutritional benefits of fish consumption propels the demand for sustainable, high-quality, and healthy meat products. Therefore, the rising consumption of fish and fish-derived products fuels the fish vaccines market growth.

Europe Fish Vaccines Market Overview

The European fish vaccines market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the fish vaccines market. The European fish vaccines market is expected to witness significant growth during the forecast period due to factors such as the significant growth in aquaculture industry, surging demand for aquatic animal-derived food products, growing research and development activities for fish vaccines development by market players in the region. Aquaculture is one of the key food-production sectors in the UK. According to the Department of Business and Trade (UK), seafood purchase is estimated to be ~US$ 5.14 billion in Great Britain. According to Innovate UK, the production value of the aquaculture industry in the UK is ~US$ 730.88 annually. Various events are organized by regulatory authorities to increase the awareness regarding the importance of maintaining aquaculture and fisheries. In May 2023, the UK's largest trade show-Aquaculture UK-for the community of aquaculture was held in Aviemore, Scotland. This trade show focused on innovation and sustainability in fish health, cleaner fish breeding, genetic selection, and other topics.

Europe Fish Vaccines Market Revenue and Forecast to 2030 (US$ Million)

Europe Fish Vaccines Market Segmentation

The Europe fish vaccines market is segmented based on vaccine type, application, route of administration, species, and country.

Based on vaccine type, the Europe fish vaccines market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest market share in 2022.

Based on application, the Europe fish vaccines market is segmented into bacterial infection, viral infection, and parasitic. The bacterial infection segment held the largest market share in 2022.

Based on route of administration, the Europe fish vaccines market is segmented into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held the largest market share in 2022.

Based on species, the Europe fish vaccines market is segmented into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022.

Based on country, the Europe fish vaccines market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The UK dominated the Europe fish vaccines market share in 2022.

Elanco Animal Health Inc, Hipra SA, Merck & Co Inc., Phibro Animal Health Corp, Vaxxinova International BV, and Zoetis Inc. are some of the leading companies operating in the Europe fish vaccines market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Europe Fish Vaccine Market

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Europe Fish Vaccine Market - Key Industry Dynamics

• 4.1 Market Drivers:
  • 4.1.1 Government Initiatives to Develop Aquaculture Industry
  • 4.1.2 Surging Demand for Aquatic Animal-Derived Food Products
• 4.2 Market Restraints
  • 4.2.1 Stringent Regulations for Approval of Vaccine
• 4.3 Market Opportunities
  • 4.3.1 Development of Novel Fish Vaccine
• 4.4 Future Trends
  • 4.4.1 Technological Advancements in Fish Vaccine
• 4.5 Impact Analysis:

5. Fish Vaccine Market - Europe Market Analysis

• 5.1 Fish Vaccine Market Revenue (US$ Th), 2022 - 2030

6. Europe Fish Vaccine Market - Revenue and Forecast to 2030 - by Vaccine Type

• 6.1 Overview
• 6.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
• 6.3 Inactivated Vaccines
  • 6.3.1 Overview
  • 6.3.2 Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
• 6.4 Live Attenuated Vaccines
  • 6.4.1 Overview
  • 6.4.2 Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
• 6.5 Subunit Vaccines
  • 6.5.1 Overview
  • 6.5.2 Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
• 6.6 Recombinant Vector Vaccine
  • 6.6.1 Overview
  • 6.6.2 Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
• 6.7 Others
  • 6.7.1 Overview
  • 6.7.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

7. Europe Fish Vaccine Market - Revenue and Forecast to 2030 - by Application

• 7.1 Overview
• 7.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
• 7.3 Bacterial Infection
  • 7.3.1 Overview
  • 7.3.2 Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
• 7.4 Viral Infection
  • 7.4.1 Overview
  • 7.4.2 Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
• 7.5 Parasitic
  • 7.5.1 Overview
  • 7.5.2 Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

8. Europe Fish Vaccine Market - Revenue and Forecast to 2030 - by Route of Administration

• 8.1 Overview
• 8.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
• 8.3 Injection vaccine
  • 8.3.1 Overview
  • 8.3.2 Injection vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
• 8.4 Immersion Vaccine
  • 8.4.1 Overview
  • 8.4.2 Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
• 8.5 Oral Vaccine
  • 8.5.1 Overview
  • 8.5.2 Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

9. Europe Fish Vaccine Market - Revenue and Forecast to 2030 - by Species

• 9.1 Overview
• 9.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
• 9.3 Salmon
  • 9.3.1 Overview
  • 9.3.2 Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
• 9.4 Trout
  • 9.4.1 Overview
  • 9.4.2 Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
• 9.5 Tilapia
  • 9.5.1 Overview
  • 9.5.2 Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
• 9.6 Others
  • 9.6.1 Overview
  • 9.6.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

10. Europe Fish Vaccine Market - Country Analysis

• 10.1 Europe Fish Vaccine Market, Revenue and Forecast to 2030
  • 10.1.1 Overview
  • 10.1.2 Europe Fish Vaccine Market, by Country
    • 10.1.2.1 UK
      • 10.1.2.1.1 Overview
      • 10.1.2.1.2 UK Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
      • 10.1.2.1.3 UK: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
      • 10.1.2.1.4 UK: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
      • 10.1.2.1.5 UK: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
      • 10.1.2.1.6 UK: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
    • 10.1.2.2 Germany
      • 10.1.2.2.1 Overview
      • 10.1.2.2.2 Germany Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
      • 10.1.2.2.3 Germany: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
      • 10.1.2.2.4 Germany: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
      • 10.1.2.2.5 Germany: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
      • 10.1.2.2.6 Germany: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
    • 10.1.2.3 France
      • 10.1.2.3.1 Overview
      • 10.1.2.3.2 France Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
      • 10.1.2.3.3 France: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
      • 10.1.2.3.4 France: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
      • 10.1.2.3.5 France: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
      • 10.1.2.3.6 France: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
    • 10.1.2.4 Italy
      • 10.1.2.4.1 Overview
      • 10.1.2.4.2 Italy Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
      • 10.1.2.4.3 Italy: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
      • 10.1.2.4.4 Italy: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
      • 10.1.2.4.5 Italy: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
      • 10.1.2.4.6 Italy: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
    • 10.1.2.5 Spain
      • 10.1.2.5.1 Overview
      • 10.1.2.5.2 Spain Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
      • 10.1.2.5.3 Spain: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
      • 10.1.2.5.4 Spain: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
      • 10.1.2.5.5 Spain: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
      • 10.1.2.5.6 Spain: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
    • 10.1.2.6 Rest of Europe
      • 10.1.2.6.1 Overview
      • 10.1.2.6.2 Rest of Europe Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
      • 10.1.2.6.3 Rest of Europe: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
      • 10.1.2.6.4 Rest of Europe: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
      • 10.1.2.6.5 Rest of Europe: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
      • 10.1.2.6.6 Rest of Europe: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)

11. Fish Vaccine Market - Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in Fish Vaccine Market
• 11.3 Inorganic Growth Strategies
  • 11.3.1 Overview
• 11.4 Organic Growth Strategies
  • 11.4.1 Overview

12. Company Profiles

• 12.1 Zoetis Inc
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 Merck & Co Inc
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 HIPRA SA
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 Phibro Animal Health Corp
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 Vaxxinova International BV
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 Elanco Animal Health Inc
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments

13. Appendix

• 13.1 About Us
• 13.2 Glossary of Terms